Alston & Bird LLP lobbying for Biomerieux, Inc.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

Utah

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Budget/Appropriations

H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.

Health Issues

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Medical/Disease Research/Clinical Labs

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Medicare/Medicaid

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Trade (domestic/foreign)

Discussions regarding tariff proposals.

Taxation/Internal Revenue Code

H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code.

Bills named in this filing 1

H.R. 1
One Big Beautiful Bill Act